Program Description
Approximately 50 million people in the United States experience acne vulgaris (AV), an inflammatory skin condition that occurs when sebum and dead skin cells clog pores. Inflammatory lesions can range in severity from mild, moderate, or severe, which can result in permanent physical scarring as well as emotional and psychological burden for patients. The majority of individuals with AV respond to acute treatment and achieve resolution with topical therapy, but many require additional skin care regimens consisting of cleansers and moisturizers. This program will review guideline-based recommendations incorporating available ceramide-containing OTC therapies in treatment regimens to help patients achieve symptom control and address the underlying pathophysiological changes that occur in AV.
Target audience: Retail pharmacists, pharmacy technicians
Type of activity: Application
Release date: April 24, 2023
Expiration date: April 24, 2025
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
Educational Objectives for Pharmacy Technicians
At the completion of this activity, participants will be able to:
- Outline the disease burden associated with acne vulgaris
- Recognize the role of ceramide-containing therapies that may be used for acne treatment
- Indicate the role of the pharmacy technician in supporting pharmacists and patients with OTC treatment strategies to individualize the care of patients with acne
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
